Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates
Go back to Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates| (NASDAQ: MDGL) | Delayed: 531.68 -9.4 (1.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $541.08 | 52 Week High | $18.24 | |||
| Open | $534.17 | 52 Week Low | $6.60 | |||
| Day High | $540.00 | P/E | N/A | |||
| Day Low | $526.67 | EPS | $0.00 | |||
| Volume | 76,870 | |||||

